357 related articles for article (PubMed ID: 25447713)
21. Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.
Zhang Y; Guo LY; Song WQ; Wang Y; Dong F; Liu G
BMC Infect Dis; 2018 May; 18(1):248. PubMed ID: 29855274
[TBL] [Abstract][Full Text] [Related]
22. The Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Colonization and Infection among Long-Term Acute Care Hospital Residents.
Mills JP; Talati NJ; Alby K; Han JH
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):55-60. PubMed ID: 26455382
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
[TBL] [Abstract][Full Text] [Related]
24. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
[TBL] [Abstract][Full Text] [Related]
25. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study.
Gómez Rueda V; Zuleta Tobón JJ
Colomb Med (Cali); 2014; 45(2):54-60. PubMed ID: 25100889
[TBL] [Abstract][Full Text] [Related]
27. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Micozzi A; Gentile G; Minotti C; Cartoni C; Capria S; Ballarò D; Santilli S; Pacetti E; Grammatico S; Bucaneve G; Foà R
BMC Infect Dis; 2017 Mar; 17(1):203. PubMed ID: 28283020
[TBL] [Abstract][Full Text] [Related]
28. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.
Akgul F; Bozkurt I; Sunbul M; Esen S; Leblebicioglu H
Pathog Glob Health; 2016; 110(7-8):321-325. PubMed ID: 27903130
[TBL] [Abstract][Full Text] [Related]
30. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
Huang W; Qiao F; Zhang Y; Huang J; Deng Y; Li J; Zong Z
Clin Infect Dis; 2018 Nov; 67(suppl_2):S225-S230. PubMed ID: 30423052
[TBL] [Abstract][Full Text] [Related]
31. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
Ariffin H; Navaratnam P; Mohamed M; Arasu A; Abdullah WA; Lee CL; Peng LH
Int J Infect Dis; 2000; 4(1):21-5. PubMed ID: 10689210
[TBL] [Abstract][Full Text] [Related]
32. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
[TBL] [Abstract][Full Text] [Related]
33. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
[TBL] [Abstract][Full Text] [Related]
34. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
[TBL] [Abstract][Full Text] [Related]
35. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.
Schwaber MJ; Klarfeld-Lidji S; Navon-Venezia S; Schwartz D; Leavitt A; Carmeli Y
Antimicrob Agents Chemother; 2008 Mar; 52(3):1028-33. PubMed ID: 18086836
[TBL] [Abstract][Full Text] [Related]
36. Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.
Pereira MR; Scully BF; Pouch SM; Uhlemann AC; Goudie S; Emond JE; Verna EC
Liver Transpl; 2015 Dec; 21(12):1511-9. PubMed ID: 26136397
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology, mortality and risk factors for patients with K. pneumoniae bloodstream infections: Clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing.
Zhang G; Zhang M; Sun F; Zhou J; Wang Y; Zhu D; Chen Z; Chen Q; Chang Q; Liu H; Chai W; Pan H
J Infect Public Health; 2020 Nov; 13(11):1710-1714. PubMed ID: 33082112
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular characteristics, risk factors and outcomes of Carbapenem-resistant
Zheng X; Wang JF; Xu WL; Xu J; Hu J
Antimicrob Resist Infect Control; 2017; 6():102. PubMed ID: 29026535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
